» Articles » PMID: 26933062

Cytokinesis Involves a Nontranscriptional Function of the Hippo Pathway Effector YAP

Overview
Journal Sci Signal
Date 2016 Mar 3
PMID 26933062
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

YAP is a transcriptional coactivator that controls organ expansion and differentiation and is inhibited by the Hippo pathway in cells in interphase. Here, we demonstrated that, during mitosis, YAP localized to the midbody and spindle, subcellular structures that are involved in cytokinesis, the process by which contraction of the cytoskeleton produces two daughter cells. Furthermore, YAP was phosphorylated by CDK1, a kinase that promotes cell cycle progression. Knockdown of YAP by shRNA or expression of a nonphosphorylatable form of YAP delayed the separation of daughter cells (called abscission) and induced a cytokinesis phenotype associated with increased contractile force, membrane blebbing and bulges, and abnormal spindle orientation. Consequently, these defects led to an increased frequency of multinucleation, micronuclei, and aneuploidy. YAP was required for proper localization of proteins that regulate contraction during cytokinesis, including ECT2, MgcRacGap, Anillin, and RHOA. In addition, depletion of YAP increased the phosphorylation of myosin light chain, which would be expected to activate the contractile activity of myosin II, the molecular motor involved in cytokinesis. The polarity scaffold protein PATJ coprecipitated with YAP and colocalized with YAP at the cytokinesis midbody, and knockdown of PATJ phenocopied the cytokinetic defects and spindle orientation alterations induced by either YAP depletion or expression of a nonphosphorylatable YAP mutant. Together, these results reveal an unanticipated role for YAP in the proper organization of the cytokinesis machinery during mitosis through interaction with the polarity protein PATJ.

Citing Articles

The Hippo effector TEAD1 regulates postnatal murine cerebellar development.

Atterton C, Pelenyi A, Jones J, Currey L, Al-Khalily M, Wright L Brain Struct Funct. 2025; 230(3):42.

PMID: 40064689 PMC: 11893647. DOI: 10.1007/s00429-025-02903-x.


MicroRNA205: A Key Regulator of Cardiomyocyte Transition from Proliferative to Hypertrophic Growth in the Neonatal Heart.

Weldrick J, Yi R, Megeney L, Burgon P Int J Mol Sci. 2024; 25(4).

PMID: 38396885 PMC: 10889831. DOI: 10.3390/ijms25042206.


TPX2 overexpression promotes sensitivity to dasatinib in breast cancer by activating YAP transcriptional signaling.

Marugan C, Sanz-Gomez N, Ortigosa B, Monfort-Vengut A, Bertinetti C, Teijo A Mol Oncol. 2024; 18(6):1531-1551.

PMID: 38357786 PMC: 11161735. DOI: 10.1002/1878-0261.13602.


Optogenetic control of YAP can enhance the rate of wound healing.

Toh P, Sudol M, Saunders T Cell Mol Biol Lett. 2023; 28(1):39.

PMID: 37170209 PMC: 10176910. DOI: 10.1186/s11658-023-00446-9.


Phosphorylation-linked complex profiling identifies assemblies required for Hippo signal integration.

Uliana F, Ciuffa R, Mishra R, Fossati A, Frommelt F, Keller S Mol Syst Biol. 2023; 19(4):e11024.

PMID: 36896621 PMC: 10090947. DOI: 10.15252/msb.202211024.


References
1.
Zhou D, Conrad C, Xia F, Park J, Payer B, Yin Y . Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell. 2009; 16(5):425-38. PMC: 3023165. DOI: 10.1016/j.ccr.2009.09.026. View

2.
Bothos J, Tuttle R, Ottey M, Luca F, Halazonetis T . Human LATS1 is a mitotic exit network kinase. Cancer Res. 2005; 65(15):6568-75. DOI: 10.1158/0008-5472.CAN-05-0862. View

3.
McPherson J, Tamblyn L, Elia A, Migon E, Shehabeldin A, Matysiak-Zablocki E . Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity. EMBO J. 2004; 23(18):3677-88. PMC: 517611. DOI: 10.1038/sj.emboj.7600371. View

4.
Niiya F, Xie X, Lee K, Inoue H, Miki T . Inhibition of cyclin-dependent kinase 1 induces cytokinesis without chromosome segregation in an ECT2 and MgcRacGAP-dependent manner. J Biol Chem. 2005; 280(43):36502-9. DOI: 10.1074/jbc.M508007200. View

5.
Tommasi S, Dammann R, Zhang Z, Wang Y, Liu L, Tsark W . Tumor susceptibility of Rassf1a knockout mice. Cancer Res. 2005; 65(1):92-8. View